Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PubMed

Risks of emergency use authorizations for medical products during outbreak situations: a COVID-19 case study.

PMID: 33008462 ·

A, l, m, i, r, , B, a, d, n, j, e, v, i, ć, ;, , L, e, j, l, a, , G, u, r, b, e, t, a, , P, o, k, v, i, ć, ;, , Z, i, j, a, d, , D, ž, e, m, i, ć, ;, , F, a, h, i, r, , B, e, č, i, ć

RevistaBiomedical engineering online
Año
PMID33008462

Resumen

The world is facing an unprecedented outbreak affecting all aspects of human lives which is caused by the COVID-19 pandemic. Due to the virus novelty, healthcare systems are challenged by a high rate of patients and the shortage of medical products. To address an increased need for essential medical products, national authorities, worldwide, made various legislative concessions. This has led to essential medical products being produced by automotive, textile and other companies from various indu

Fuente oficial

Ver en PubMed →

Datos obtenidos de PubMed / NCBI. Para consultar el texto completo y la información más reciente, remítase siempre al registro oficial.

↑